The reported meeting signals potential changes to improve shareholder value after weak stock performance.
CVS’s stock rises nearly 2% on report of meeting with hedge fund Glenview Capital
RELATED ARTICLES
The reported meeting signals potential changes to improve shareholder value after weak stock performance.